skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cyclic, low-dose total body irradiation for metastatic neuroblastoma

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

Total body irradiation (TBI) can be thought of as a systemic anticancer agent. It therefore might best be given like an adjuvant drug, i.e., in tolerable doses, cyclically. The therapeutic ratio between normal bone marrow stem cells and suitably sensitive cancer cells should be widened by these means. Fourteen children with advanced (Stage IV) neuroblastomas were given 100-150 rad TBI in 50 rad daily fractions along with each three-week cycle of standard triple-agent chemotherapy (vincristine, DTIC, cyclophosphamide). Two patients died of toxicity and one is still undergoing therapy. Four of the remaining 12 survive free of disease for 12+ to 31+ months. The regimen is well tolerated, but prolonged, pronounced bone marrow depression, especially thrombocytopenia, commonly occurs after doses of 300-450 rad.

Research Organization:
Univ. of Pennsylvania, Philadelphia
OSTI ID:
5016603
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 9:12
Country of Publication:
United States
Language:
English

Similar Records

Fractionated total body irradiation for metastatic neuroblastoma
Journal Article · Sun Nov 01 00:00:00 EST 1981 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5016603

Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology
Journal Article · Sat Apr 01 00:00:00 EST 2006 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5016603

Systemic irradiation for selected stage IV and recurrent pediatric solid tumors: method, toxicity, and preliminary results
Conference · Fri Feb 01 00:00:00 EST 1980 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5016603